Goldman Sachs Group Inc Cortexyme, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 May 14, 2024	SELL	$1.29 - $2.52 $75,795 - $148,065	-58,756 Reduced 66.5%	29,598 $39,000
Q3 2022 Nov 10, 2022	SELL	$1.29 - $2.52 $75,795 - $148,065	-58,756 Reduced 66.5%	29,598 $0
Q2 2022 May 14, 2024	BUY	$2.22 - $6.7 $196,145 - $591,971	88,354 New	88,354 $196,000
Q2 2022 Aug 15, 2022	BUY	$2.22 - $6.7 $59,391 - $179,245	26,753 Added 43.43%	88,354 $196,000
Q1 2022 May 16, 2022	SELL	$4.18 - $13.39 $257,826 - $825,908	-61,681 Reduced 50.03%	61,601 $381,000
Q4 2021 Feb 14, 2022	BUY	$11.35 - $97.17 $935,705 - $8.01 Million	82,441 Added 201.86%	123,282 $1.56 Million
Q3 2021 Nov 10, 2021	BUY	$52.0 - $120.21 $2.12 Million - $4.91 Million	40,841 New	40,841 $3.74 Million

Others Institutions Holding CRTX

# of Institutions

39

Shares Held

5.21M

Call Options Held

90.8K

Put Options Held

0

Vanguard Group Inc Valley Forge, PA

1.2M
Shares

$1.55 Million
0.0% of portfolio
Epiq Capital Group, LLC San Francisco, CA

826K
Shares

$1.07 Million
0.32% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

523K
Shares

$674,123
0.0% of portfolio
Almitas Capital LLC Santa Monica, CA

383K
Shares

$493,917
0.23% of portfolio
Black Rock Inc. New York, NY

355K
Shares

$457,676
0.0% of portfolio

About Cortexyme, Inc.

Ticker CRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,150,800
Market Cap $70.5M

More about CRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.